Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Oligo (dT) 25 Beads: Precision Tools for Advanced mRNA Profi
2026-05-21
Explore the science behind Oligo (dT) 25 Beads for eukaryotic mRNA isolation and their impact on experimental reproducibility. This in-depth review uniquely connects molecular workflow optimization with translational research advances.
-
Peptidisc-Assisted Nanobody Multimerization: Expanding Prote
2026-05-21
This study introduces a peptidisc-based method to cluster nanobodies into multimeric or multispecific assemblies, greatly enhancing binding affinity and functional diversity. The approach leverages hydrophobic transmembrane segments and amphipathic stabilization, offering new avenues for protein engineering and affinity assays.
-
Technical Guide: HyperPFU™ High-Fidelity DNA Polymerase in P
2026-05-20
HyperPFU™ high-fidelity DNA polymerase addresses the need for robust, accurate PCR amplification of long or GC-rich DNA templates where standard polymerases often fail due to low fidelity or processivity. It is best applied to workflows requiring blunt-ended, high-fidelity products, but not for protocols needing 3'-A overhangs or sticky ends.
-
Capsaicin: Mechanistic Powerhouse for Translational Pain Res
2026-05-20
Explore how (E)-Capsaicin—a dual TRPV1 activator and KDM1A/LSD1 inhibitor—redefines the landscape of translational research in pain, inflammation, and cancer. This article integrates mechanistic insights, data-driven protocols, and strategic guidance for researchers aiming to bridge the gap from bench to bedside, while highlighting competitive context and future directions.
-
Cisplatin (A8321): Breakthroughs in Chemosensitivity and EMT
2026-05-19
Explore the multifaceted role of Cisplatin in cancer research, focusing on its mechanisms, experimental best practices, and new insights into chemosensitivity and EMT modulation. This article examines cutting-edge findings that distinguish Cisplatin applications and optimize apoptosis and chemoresistance studies.
-
Ruthenium Red: Precision Ca2+ Transport Inhibitor for Autoph
2026-05-19
Ruthenium Red is a gold-standard Ca2+ transport inhibitor that enables precise dissection of cytoskeleton-dependent calcium signaling and autophagy. This guide delivers actionable protocols, troubleshooting strategies, and translational insights from the latest mechanotransduction research, supporting reproducible success in advanced cell signaling studies.
-
Nonivamide (Capsaicin Analog): TRPV1 Agonism in Cancer and I
2026-05-18
Explore how Nonivamide, a capsaicin analog, enables precise TRPV1 modulation for both cancer growth inhibition and inflammation control. This article uniquely bridges molecular mechanism, in vivo efficacy, and protocol strategy for advanced research.
-
Lanabecestat (AZD3293): Reliable BACE1 Inhibition in AD Rese
2026-05-18
This article provides a scenario-driven, evidence-based exploration of Lanabecestat (AZD3293), SKU BA8438, for Alzheimer's disease research. It addresses real laboratory challenges in amyloid-beta production inhibition, experimental design, and product selection, guiding researchers toward reproducible and synaptic-sparing protocols. Direct comparisons and protocol recommendations highlight Lanabecestat's validated performance.
-
Nonivamide: A Capsaicin Analog for Cancer and Inflammation M
2026-05-17
Nonivamide, a potent capsaicin analog, empowers researchers to selectively activate TRPV1 pathways for targeted cancer cell inhibition and neuroimmune modulation. With robust evidence for both anti-proliferative and anti-inflammatory actions, it offers reproducible workflows and troubleshooting insights for translational studies.
-
PEO Chain Density Modulates Uremic Toxin Adsorption Dynamics
2026-05-16
This study dissects how end-tethered methoxy-PEO (m-PEO) chain density on gold surfaces influences the adsorption of clinically relevant uremic toxins, including 4-ethylphenyl sulfate. By integrating surface characterization and targeted LC/MS analytics, the research advances understanding of biomaterial–toxin interactions critical for renal and gut-brain axis research.
-
Ceftolozane-Tazobactam in Nosocomial Pneumonia: Structural a
2026-05-15
The reference study elucidates the molecular and pharmacological innovations of ceftolozane-tazobactam in treating nosocomial pneumonia, especially its efficacy against multidrug-resistant Pseudomonas aeruginosa. By dissecting structure–activity relationships and clinical outcomes, the paper guides researchers in designing infection models and benchmarking alternative cephalosporins.
-
Pterostilbene Protects the BBB in Ischemic Stroke via Cytosk
2026-05-15
This study demonstrates that pterostilbene, a natural compound found in blueberries and grapes, confers neuroprotection in cerebral ischemia/reperfusion (I/R) injury by stabilizing the blood–brain barrier (BBB). The work uncovers dual-stage mechanisms: early cytoskeletal stabilization and late Wnt pathway activation, providing insight into multi-target strategies for stroke therapy.
-
Capsaicin: TRPV1 Activation and KDM1A Inhibition in Research
2026-05-14
Capsaicin ((E)-Capsaicin) is a dual-acting compound that activates TRPV1 ion channels and inhibits KDM1A/LSD1. Its roles span pain, itch, and cancer models. APExBIO's C6366 product provides high purity, validated for mechanistic and translational research.
-
Capsazepine: TRPV1 Ion Channel Antagonist in Pain Research
2026-05-14
Capsazepine from APExBIO empowers researchers to dissect TRPV1-mediated nociception and apoptosis mechanisms with nanomolar potency and workflow flexibility. Learn how to optimize experimental protocols, troubleshoot common challenges, and leverage recent cross-domain insights for robust pain and cancer research outcomes.
-
Metronidazole: OAT3 Inhibition & Antibiotic Benchmarking
2026-05-13
Metronidazole (2-(2-methyl-5-nitroimidazol-1-yl)ethanol) is a nitroimidazole antibiotic and potent OAT3 inhibitor. It offers high-purity, reproducible inhibition for research on anaerobic bacteria and protozoa. APExBIO’s validated product enables reliable modulation of drug transport and interaction studies.